Fabrinet에 대한 매도 수량은 투자자에게 Fabrinet의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Fabrinet (NYSE:FN) 주식, 공매도 수량 보고

Fabrinet

Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

Nvidia’s Wild Ride

Analyst Color

Long Ideas

News

Events

Analyst Ratings

Tech

Trading Ideas

COHR

DELL

NVDA

SMCI

모든 시선은 엔비디아(NASDAQ:NVDA)의 GTC 2025에 집중되고 있다. CEO 젠슨 황이 인공지능(AI) 하드웨어의 다음 단계를 공개할 예정이다. JP모건의 애널리스트 사믹 채터지(Samik Chatterjee)는 투자자들이 하드웨어와 네트워킹 공급망의 승자와 패자를 분석하기 위해 이 이벤트를 주의 깊게 지켜보아야 할 주요 포인트를 정리했다.

엔비디아의 다음 움직임이 암페놀, 델, 슈퍼 마이크로에 중요한 이유

The Decline

Earnings

Pre-Market Outlook

Markets

NXPI

TBNK

월요일(3일) 아침 미국 주식 선물이 하락세를 보이면서 오늘 투자자들의 관심을 끌 수 있는 주식은 다음과 같다. 월요일 주목해야 할 주식: 타이슨 푸드, 크로락스, 테리토리얼 뱅코프, 패브리넷 및 NXP 세미컨덕터

월요일 주목해야 할 주식: 타이슨 푸드, 크로락스, 테리토리얼 뱅코프, 패브리넷 및 NXP 세미

Small Cap.Euro

Broad U.S. Equity ETFs

Specialty ETFs

Small Cap Analysis

Small Cap

Exclusives

Interview

ETFs

AVSC

PSCT

SPSC

VTWO

최근 벤징가(Benzinga)와의 독점 인터뷰에서 러셀 인베스트먼트(Russell Investments)의 북미 최고 투자 전략가인 폴 아이텔만(Paul Eitelman)은 경제적 불확실성 속에서 눈에 띄는 소형주 부문에 대한 통찰력을 제공했다.

단독: 러셀의 전략가가 낮은 금리 환경에서 기회를 잡으며 최고의 소형주들을 발견

PARAGON 28 INC COM

EVOLUTIONARY GENOMICS INC by Evolutionary Genomics, Inc.

Evolutionary Genomics Inc

FOUR NINES GOLD INC by FOUR NINES GOLD INC.

Four Nines Gold Inc

F N B Corp

FINECOBANK SPA UNSP/ADR by Finecobank Banca Fineco SPA

FinecoBank SpA

FINBAR GROUP LTD by Finbar Group Ltd.

FINEMARK HOLDINGS INC by FineMark Holdings, Inc.

FineMark Holdings Inc

FNCB Bancorp Inc Com

Covivio SA

FINCH THERAPEUTCS GRP INC by Finch Therapeutics Group, Inc.

Finch Therapeutics Group Inc

FINEOS Corp Holdings PLC Chess Depository Interest

FINEOS Corp Holdings PLC

FANCAMP EXPLORATION LTD by Fancamp Exploration Ltd.

Fancamp Exploration Ltd

Fidelity MSCI Financials Index ETF

Fincantieri SpA

FINANCIERA INDEP SAB ORD by Financiera Independencia Sab De Cv

Financiera Independencia SAB de CV Sofom E N R

NORTH AMER FINCL 15 SPLIT by North American Financial 15 Split Corp

North American Financial 15 Split Corp

Orange SA

Floor & Decor Holdings, Inc. Common Stock

Floor & Decor Holdings Inc

Schwab Fundamental U.S. Small Company ETF

Schwab Fundamental U.S. Broad Market ETF

Schwab Fundamental International Small Equity ETF

Schwab Fundamental Emerging Markets Equity ETF

Schwab Fundamental International Equity ETF

Fund.com Inc

FVI Fondo De Valores Inmobiliarios SACA ADR

FRIENDTIMES INC by FRIENDTIMES INC.

Schwab Fundamental U.S. Large Company ETF

FNDZ

FIRST NATIONAL ENERGY CRP by First National Energy Corp.

First National Energy Corp

Fastned BV

FRASER & NEAVE LTD by Fraser & Neave Ltd.

Fraser and Neave Ltd

FRASER & NEAVE UNSP/ADR by Fraser & Neave Ltd.

FNF Group of Fidelity National Financial, Inc. Common Stock

Fidelity National Financial Inc

FIRST NILES FINCL INC by First Niles Financial, Inc.

First Niles Financial Inc

FIRST NILES FINCL PFD A by First Niles Financial, Inc.

MicroSectors FANG Index 3X Leveraged ETNs due January 8, 2038

Bank Of Montreal MicroSectors FANG+ 3X Leveraged ETNs

MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038

Direxion Daily NYSE FANG+ Bull 2X Shares

ODESSA MINERALS LTD by ODESSA MINERALS LTD

MicroSectors FANG Index 2X Leveraged ETNs due January 8, 2038

FingerMotion Inc

MicroSectors FANG ETNs due January 8, 2038

Bank of Montreal (Quebec) MICROSECTORS FANG+ INDEX 3X LEVERAGED ETN

FedNat Holding Co

Fathom Nickel Inc

49 NORTH RES INC by 49 North Resources , Inc.

49 North Resources Inc

First Trust Mid Cap Value AlphaDEX Fund

Funko Inc

First Bancorp Inc

FIRST NATIONAL FINL CORP by First National Financial Corp.

First National Financial Corp

Fresnillo PLC

Federal National Mortgage Association Fannie Mae

FIRST NORDIC METALS CORP by FIRST NORDIC METALS CORP.

First Nordic Metals Corp

FINANCIAL 15 SPL CORP by Financial 15 Split Corp

Financial 15 Split Corp

Finnair Oyj

Flatex AG

FINCANNA CAPITAL CORP by Fincanna Capital Corp.

FinCanna Capital Corp

FURUNO ELECTRIC CO LTD by Furuno Electric Co. Ltd.

Furuno Electric Co Ltd

FT Vest U.S. Equity Buffer ETF - November

Fortnox AB

Fineqia International Inc

1st NRG Corp

FIRST NTHN COMMUNTY BNCRP by First Northern Community Bancorp

First Northern Community Bancorp

Fronteo Inc

XR Immersive Tech Inc

XR IMMERSIVE TECH INC by XR IMMERSIVE TECH INC.

Metaplanet Inc

Franco-Nevada Corp

FINNOVATE ACQUISITION CORP CL A

FINNOVATE ACQ CORP A by Finnovate Acquisition Corp.

Finnovate Acquisition Corp

FINNOVATE ACQUISITION CORP WT EXP

Finnovate Acquisition Corp Units (1 Ord Class A & 3/4 War)

Finnovate Acquisition Corp Warrants (30/09/2026)

First Northwest Bancorp

Finward Bancorp

First Trust Mid Cap Core AlphaDEX Fund

Fabrinet&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) shares are trading lower on Tuesday after it reported <a href="https://www.benzinga.com/pressreleases/25/05/g45207128/fabrinet-announces-third-quarter-fiscal-year-2025-financial-results" target="_blank" rel="noreferrer noopener">third-quarter FY25 results on Monday</a>.
Revenue was&nbsp;$871.8&nbsp;million, beating the consensus of&nbsp;$856.62 million. Adjusted EPS&nbsp;of&nbsp;$2.52 exceeded<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">&nbsp;the consensus of&nbsp;$2.49</a>.
Fabrinet CEO Seamus Grady said, &#8220;We delivered another strong telecom performance with growth that more than offset an anticipated sequential decline in datacom revenue. Our team continued to execute very well, producing non-GAAP EPS that also exceeded our guidance.&#8221;
&#8221;Looking ahead, we remain optimistic and confident in our ability to deliver strong execution in the fourth quarter and into fiscal 2026.&#8221;
As of March 28, cash and cash equivalents stood at $306.9 million.
Outlook: Fabrinet expects&nbsp;fourth-quarter&nbsp;FY25 revenue of&nbsp;$860&nbsp;million&nbsp;–&nbsp;$900&nbsp;million, surpassing&nbsp;<a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">the street view of&nbsp;$888.62 million</a>.
The company also projects fourth-quarter adjusted EPS of&nbsp;$2.50-$2.70&nbsp;vs. the street view of&nbsp;$2.69.
Rosenblatt analyst Mike Genovese raised the price forecast from $230 to $250, <a href="https://www.benzinga.com/quote/FN/analyst-ratings" target="_blank" rel="noreferrer noopener">while retaining a Buy rating</a>.
The analyst says that Fabrinet&#8217;s outlook in the Telecom sector has become increasingly attractive, and expects Telecom revenue to continue its sequential growth trajectory as both Data Center Interconnect (DCI) and traditional Telecommunications markets rebound.
Also, Genovese writes that Fabrinet is poised to benefit from contract wins with major players like Cisco, Infinera, and Ciena. Simultaneously, investors might observe a less robust performance in the Datacom segment. That may not come as a significant surprise, adds the analyst.
The analyst revised EPS estimates to $10.15 (from $10.17) for 2025 and reiterated FY26 estimates at $11.20.
Investors can gain exposure to the stock via&nbsp;Janus Henderson Small/Mid Cap Growth Alpha ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSMD#NASDAQ">JSMD</a>) and Principal U.S. Small-Cap ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSC#NASDAQ">PSC</a>).
Price Action: FN shares are down 7.18% at $205.03 at the last check on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/asset-sales/25/05/45193332/ackmans-900-million-power-play-pershing-square-takes-massive-stake-in-howard-hughes-with-48-premium" target="_blank" rel="noreferrer noopener">Ackman&#8217;s $900 Million Power Play: Pershing Square Takes Massive Stake In Howard Hughes With 48% Premium</a></li>
</ul>
Image: Shutterstock

Equities

Mid Cap

Guidance

Movers

JSMD

Fabrinet Wows Wall Street, But Shares Slide On Mixed Outlook

Wall Street edged lower by midday Tuesday as uncertainty surrounding trade policies lingered, with investors adopting a cautious approach ahead of <a href="https://www.benzinga.com/topic/federal-reserve">Wednesday&#8217;s Federal Reserve meeting.</a>
In a meeting with Canadian Prime Minister Mark Carney, President Donald Trump suggested the U.S. may soon begin renegotiating the USMCA. He noted that China is eager to negotiate due to its struggling economy, driven by a lack of U.S. trade, but emphasized the talks would take place &#8220;at the right time.&#8221;
Trump kept his trade stance unclear, suggesting that while some agreements may be signed, there is no obligation to finalize any, and dismissed repeated questions about the number of deals in progress.
The S&amp;P 500 dipped 30 points, or 0.6%, to 5,610, on track for its second consecutive negative session after nine straight gains. The Nasdaq 100 dropped 0.8%, while the Russell 2000 slipped 1%.
Ten of the 11 S&amp;P 500 sectors were in the red, with utilities as the only sector in the green. The U.S. dollar fell, extending its losses for a third straight session.
Commodities saw a broad rally, with oil prices surging 3.6%, pushing WTI above $59, following <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45224883/oil-soars-above-59-as-middle-east-airstrikes-jolt-markets">Israeli airstrikes in Yemen</a>. Gold also rallied, climbing 2.4% to above $3,400 per ounce amid heightened geopolitical tensions.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) reversed Monday's gains, slipping 0.4% to $94,375.
<h1 class="wp-block-heading">Tuesday&#8217;s Performance In Major U.S. Indices, ETFs</h1>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day % chg</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,614.65</td>
<td>-0.6%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>40,905.06</td>
<td>-0.8%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>19,796.10</td>
<td>-0.9%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1,983.93</td>
<td colspan="2">-1.0%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated by 12:55 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.7% to $559.24.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) eased 0.8% to $409.01.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;fell 0.9% to $481.23.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) tumbled 1.1% to $196.68.</li>
<li>The&nbsp;Utilities&nbsp;Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) outperformed, up 1.2%; the&nbsp;Health Care&nbsp;Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>) lagged, down 2.4%.</li>
</ul>
<h1 class="wp-block-heading">Tuesday&#8217;s Stock Movers</h1>
Stocks reacting to earnings reports included: 
<ul>
<li>Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) up 2.70%</li>
<li>The Clorox Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) down 2.31%</li>
<li>Coterra Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) down 9.95%</li>
<li>Vertex Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) down 13.9%</li>
<li>Diamondback Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) down 0.53%</li>
<li>Realty Income Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) down 0.68%</li>
<li>The Williams Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) down 5.19%</li>
<li>Celanese Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) up 9.14%</li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) down 7.37%</li>
<li>Lattice Semiconductor Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) down 13.6%</li>
<li>Mattel Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAT#NASDAQ">MAT</a>) up 3.61%</li>
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) down 13.6%</li>
<li>Duke Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DUK#NYSE">DUK</a>) up 2.24%</li>
<li>Constellation Energy Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>) up 10.94%</li>
<li>TransDigm Group Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDG#NYSE">TDG</a>) down 5.67%</li>
<li>Marriott International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) up 1.26%</li>
<li>Zoetis Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZTS#NYSE">ZTS</a>) down 3.32%</li>
<li>American Electric Power Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEP#NASDAQ">AEP</a>) up 0.52%</li>
<li>Marathon Petroleum Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPC#NYSE">MPC</a>) up 0.37%</li>
<li>Fidelity National Information Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIS#NYSE">FIS</a>) down 2.88%</li>
<li>WEC Energy Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEC#NYSE">WEC</a>) up 0.77%</li>
<li>Gartner, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IT#NYSE">IT</a>) up 1.14%</li>
<li>IQVIA Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IQV#NYSE">IQV</a>) down 1.32%</li>
<li>Archer-Daniels-Midland Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) up 2.02%</li>
<li>Waters Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAT#NYSE">WAT</a>) down 4.43%</li>
<li>Leidos Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDOS#NYSE">LDOS</a>) up 4.11%</li>
<li>Global Payments Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPN#NYSE">GPN</a>) down 1.43%</li>
<li>GlobalFoundries Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GFS#NASDAQ">GFS</a>) down 3.57%</li>
<li>Expeditors International of Washington, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXPD#NYSE">EXPD</a>) down 3.67%</li>
<li>Ball Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BALL#NYSE">BALL</a>) up 0.55%</li>
<li>Jacobs Solutions Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/J#NYSE">J</a>) down 5.56%</li>
</ul>
Stocks slated to report earnings after the close include: Assurant Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIZ#NYSE">AIZ</a>), Arista Networks Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>), Gen Digital Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEN#NASDAQ">GEN</a>), Advanced Micro Devices Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), International Flavors &amp; Fragrances Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IFF#NYSE">IFF</a>), Electronic Arts Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EA#NASDAQ">EA</a>), Mosaic Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOS#NYSE">MOS</a>), Corpay Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPAY#NYSE">CPAY</a>), Wynn Resorts Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WYNN#NASDAQ">WYNN</a>), Jack Henry &amp; Associates Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JKHY#NASDAQ">JKHY</a>), Devon Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>), Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>), Coty Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COTY#NYSE">COTY</a>) and Rivian Automotive Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>).
Read now: 
<ul>
<li><a href="https://www.benzinga.com/news/large-cap/25/05/45205780/sp-500-stocks-that-defy-sell-in-may-myth-5-companies-with-strong-historical-gains">S&amp;P 500 Stocks That Defy &#8216;Sell In May&#8217; Myth: 5 Companies With Strong Historical Gains</a></li>
</ul>
Photo: Gumbariya via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Government

Large Cap

Macro Economic Events

Regulations

Sector ETFs

Commodities

Global

Econ #s

Economics

$BTC

ANET

BALL

COTY

CPAY

CTRA

SPDR Dow Jones Industrial Average ETF Trust

EXPD

FANG

JKHY

LDOS

LSCC

PLTR

RIVN

VRTX

WYNN

Select Sector SPDR-Consumer Discretionary

Stocks Fall On Trade Concerns, Oil And Gold Rally: What's Driving Markets Tuesday?

Barclays analyst George Wang maintains Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) with a Equal-Weight and lowers the price target from $245 to $234.

Price Target

Barclays Maintains Equal-Weight on Fabrinet, Lowers Price Target to $234

JP Morgan analyst Samik Chatterjee maintains Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) with a Neutral and raises the price target from $220 to $235.

JP Morgan Maintains Neutral on Fabrinet, Raises Price Target to $235

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Needham cut ON Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) price target from $57 to $50. Needham analyst Quinn Bolton maintained a Buy rating. ON Semiconductor shares closed at $38.41 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/ON/analyst-ratings">view this stock</a>.</li>
<li>Compass Point slashed the price target for MARA Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) from $25 to $9.5. Compass Point analyst Joe Flynn downgraded the stock from Neutral to Sell. MARA Holdings shares closed at $13.09 on Monday. <a href="https://www.benzinga.com/quote/MARA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Leerink Partners cut Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) price target from $550 to $503. Leerink Partners analyst David Risinger downgraded the stock from Outperform to Market Perform. Vertex Pharmaceuticals shares closed at $500.19 on Monday. See how other analysts view <a href="https://www.benzinga.com/quote/VRTX/analyst-ratings">this stock</a>.</li>
<li>HC Wainwright &amp; Co. raised the price target for Solaris Resources Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLSR#NYSE">SLSR</a>) from $10 to $11. HC Wainwright &amp; Co. analyst Heiko Ihle maintained a Buy rating. Solaris Resources shares closed at $4.33 on Monday. <a href="https://www.benzinga.com/quote/SLSR/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Telsey Advisory Group slashed the price target for Ethan Allen Interiors Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETD#NYSE">ETD</a>) from $32 to $30. Telsey Advisory Group analyst Cristina Fernandez maintained a Market Perform rating. Ethan Allen Interiors shares closed at $29.13 on Monday. See how other analysts <a href="https://www.benzinga.com/quote/ETD/analyst-ratings">view this stock</a>.</li>
<li>Rosenblatt raised Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) price target from $230 to $250. Rosenblatt analyst Mike Genovese maintained a Buy rating. Fabrinet shares settled at $220.90 on Monday. <a href="https://www.benzinga.com/quote/FN/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Telsey Advisory Group cut NIKE, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) price target from $80 to $70. Telsey Advisory Group analyst Cristina Fernandez maintained a Market Perform rating. Nike shares closed at $57.35 on Monday. <a href="https://www.benzinga.com/quote/NKE/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity cut Castle Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) price target from $42 to $37. Canaccord Genuity analyst Kyle Mikson maintained a Buy rating. Castle Biosciences shares closed at $18.75 on Monday.  <a href="https://www.benzinga.com/quote/cstl/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan cut the price target for Twist Bioscience Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWST#NASDAQ">TWST</a>) from $40 to $33. JP Morgan analyst Rachel Vatnsdal maintained an Underweight rating. Twist Bioscience shares settled at $35.93 on Monday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan raised Quest Diagnostics Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) price target from $180 to $190. JP Morgan analyst Lisa Gill maintained a Neutral rating. Quest Diagnostics shares closed at $177.57 on Monday. <a href="https://www.benzinga.com/quote/DGX/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying NKE stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="581" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06080300/image-53-1024x581.png" alt="" class="wp-image-903102" style="width:591px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06080300/image-53-1024x581.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06080300/image-53-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06080300/image-53-768x436.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/06080300/image-53.png 1116w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45192607/jim-cramer-applied-materials-is-an-excellent-company-but-likes-this-tech-stock-more">Jim Cramer Says Applied Materials Is An &#8216;Excellent&#8217; Company, But Likes This Tech Stock More</a> </li>
</ul>
Photo via Shutterstock

CSTL

MARA

SLSR

TWST

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday

U.S. stock futures were lower this morning, with the Dow futures falling over 200 points on Tuesday.
Shares of Ichor Holdings, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICHR#NASDAQ">ICHR</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected first-quarter financial results and issued second-quarter <a href="https://www.benzinga.com/quote/ICHR/earnings">guidance below estimates</a>.
Ichor Hldgs reported quarterly earnings of 12 cents per share which missed the analyst consensus estimate of 26 cents per share. The company reported quarterly sales of $244.47 million which missed the analyst consensus estimate of $244.95 million.
Ichor Holdings shares dipped 14.8% to $17.75 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Hyperscale Data, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPUS#NYSE">GPUS</a>) dipped 17.2% to $6.42 in pre-market trading. Hyperscale Data shares jumped 466% on Monday after the company issued FY25 sales guidance.</li>
<li>Immutep Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMMP#NASDAQ">IMMP</a>) fell 13.3% to $2.16 in pre-market trading. Immutep shares jumped over 45% on Monday after the company provided updates for cohort B of its Tacti-003 Phase IIb trial.</li>
<li>Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) fell 8.4% to $113.45 in pre-market trading. Palantir reported in-line earnings for its first quarter on Monday. Palantir reported first-quarter revenue of $883.86 million, beating analyst estimates of $862.83 million. The company reported first-quarter adjusted earnings of 13 cents per share, in line with analyst estimates. The company also raised its full-year guidance.</li>
<li>Castle Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTL#NASDAQ">CSTL</a>) fell 7.7% to $17.30 in pre-market trading following downbeat quarterly earnings.</li>
<li>Arcus Biosciences, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RCUS#NYSE">RCUS</a>) fell 7.1% to $8.31 in pre-market trading.</li>
<li>Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) fell 6.8% to $206.00 in today's pre-market trading after the company reported third-quarter results and issued fourth-quarter guidance with its midpoint below estimates.</li>
<li>EverQuote, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) declined 5.1% to $25.00 in pre-market trading following first-quarter results.</li>
<li>Vertex Pharmaceuticals Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) fell 5% to $475.00 in pre-market trading after the company reported worse-than-expected first-quarter financial results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/05/45192607/jim-cramer-applied-materials-is-an-excellent-company-but-likes-this-tech-stock-more">Jim Cramer Says Applied Materials Is An &#8216;Excellent&#8217; Company, But Likes This Tech Stock More</a> </li>
</ul>
Photo via Shutterstock

EVER

GPUS

ICHR

IMMP

RCUS

Ichor Holdings Posts Weak Earnings, Joins Fabrinet, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

WIIM

Fabrinet Ordinary shares are trading lower. The company reported Q3 financial results

Needham analyst Ryan Koontz reiterates Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) with a Buy and maintains $280 price target.

Reiteration

Needham Reiterates Buy on Fabrinet, Maintains $280 Price Target

Rosenblatt analyst Mike Genovese maintains Fabrinet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FN#NYSE">FN</a>) with a Buy and raises the price target from $230 to $250.

Comments

Fabrinet

매도 수량

Fabrinet (NYSE:FN) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌